Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters
- PMID: 18595142
- PMCID: PMC2719238
- DOI: 10.3748/wjg.14.3739
Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters
Abstract
Aim: To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC).
Methods: An immunohistochemical study of E-cadherin and P120 catenin was performed on 42 specimens of ICC with a Dako Envision kit.
Results: The expression of E-cadherin and P120 was reduced in 27 cases (64.3%) and 31 cases (73.8%), respectively. Both E-cadherin and P120 expressions were significantly correlated with the tumor histological grade (chi2 = 9.333, P = 009 and chi2 = 11.71, P = 0.003), TNM stage (chi2= 8.627, P = 0.035 and chi2 = 13.123, P = 0.004), intrahepatic metastasis (chi2= 7.292, P = 0.007 and chi2 = 4.657, P = 0.041, respectively) and patients' survival (chi2= 6.351, P = 0.002 and chi2 = 4.023, P = 0.000, respectively). In addition, the expression of P120 was in concordance with that of E-cadherin (chi2 = 13.797, P = 0.000), indicating that the expression of P120 may be dependent on that of E-cadherin. Finally, only P120 expression was found to be an independent prognostic factor in Cox regression model (r = 0.088, P = 0.049).
Conclusion: Down-regulated expression of E-cadherin and P120 occurs frequently in ICC and contributes to the progression and development of tumor. Both of them may be valuable biologic markers for predicting tumor invasion, metastasis and patients' survival, but only P120 is an independent prognostic factor for ICC.
Figures
Similar articles
-
Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.World J Gastroenterol. 2008 Oct 7;14(37):5665-73. doi: 10.3748/wjg.14.5665. World J Gastroenterol. 2008. PMID: 18837082 Free PMC article.
-
Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.Hepatobiliary Pancreat Dis Int. 2008 Feb;7(1):70-5. Hepatobiliary Pancreat Dis Int. 2008. PMID: 18234642
-
Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma.J Clin Pathol. 2014 Mar;67(3):229-34. doi: 10.1136/jclinpath-2013-201806. Epub 2013 Sep 23. J Clin Pathol. 2014. PMID: 24062361
-
Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer.Semin Cell Dev Biol. 2004 Dec;15(6):657-63. doi: 10.1016/j.semcdb.2004.09.003. Semin Cell Dev Biol. 2004. PMID: 15561585 Review.
-
P120 and E-cadherin: Double-edged swords in tumor metastasis.Semin Cancer Biol. 2020 Feb;60:107-120. doi: 10.1016/j.semcancer.2019.07.020. Epub 2019 Jul 29. Semin Cancer Biol. 2020. PMID: 31369816 Review.
Cited by
-
Altered localization of p120 catenin in the cytoplasm rather than the membrane correlates with poor prognosis in esophageal squamous cell carcinoma.PLoS One. 2015 Mar 18;10(3):e0118645. doi: 10.1371/journal.pone.0118645. eCollection 2015. PLoS One. 2015. PMID: 25785604 Free PMC article.
-
Altered expression of p120catenin predicts poor outcome in invasive breast cancer.J Cancer Res Clin Oncol. 2010 Sep;136(9):1377-87. doi: 10.1007/s00432-010-0789-8. Epub 2010 Feb 12. J Cancer Res Clin Oncol. 2010. PMID: 20151151
-
Periostin promotes malignant potential by induction of epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.Hepatol Commun. 2017 Oct 25;1(10):1099-1109. doi: 10.1002/hep4.1114. eCollection 2017 Dec. Hepatol Commun. 2017. PMID: 29404445 Free PMC article.
-
Functions of p120-catenin in physiology and diseases.Front Mol Biosci. 2024 Oct 21;11:1486576. doi: 10.3389/fmolb.2024.1486576. eCollection 2024. Front Mol Biosci. 2024. PMID: 39498333 Free PMC article. Review.
-
c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells.Clin Exp Metastasis. 2011 Apr;28(4):391-404. doi: 10.1007/s10585-011-9378-8. Epub 2011 Feb 20. Clin Exp Metastasis. 2011. PMID: 21336985 Free PMC article.
References
-
- Reynolds AB, Herbert L, Cleveland JL, Berg ST, Gaut JR. p120, a novel substrate of protein tyrosine kinase receptors and of p60v-src, is related to cadherin-binding factors beta-catenin, plakoglobin and armadillo. Oncogene. 1992;7:2439–2445. - PubMed
-
- Nollet F, Berx G, van Roy F. The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun. 1999;2:77–85. - PubMed
-
- Xiao K, Oas RG, Chiasson CM, Kowalczyk AP. Role of p120-catenin in cadherin trafficking. Biochim Biophys Acta. 2007;1773:8–16. - PubMed
-
- Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353–1357. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous